Invitrogen Corporation (Invitrogen) is a developer, manufacturer and marketer of research tools in reagent, kit and high-throughput applications forms to customers engaged in life sciences research, drug discovery, diagnostics and the commercial manufacture of biological products. The... more

Amgen Inc. is a biotechnology company that discovers, develops, manufactures and markets human therapeutics-based on advances in cellular and molecular biology. The Company operates in human therapeutics. It markets human therapeutic products in the areas of supportive cancer care,... more

Genentech, Inc. (Genentech) is a biotechnology company that discovers, develops, manufactures and commercializes pharmaceutical products to treat patients with unmet medical needs. It commercializes multiple biotechnology products and also receives royalties from companies that are... more

Genzyme Corporation is a biotechnology company. The Company operates in six units. Renal develops, manufactures and distributes products that treat patients suffering from renal diseases, including chronic renal failure. Therapeutics develops, manufactures and distributes therapeutic... more

ImClone Systems Incorporated (ImClone) is a biopharmaceutical company that develops a portfolio of targeted biologic treatments designed to address the medical needs of patients with cancer. The Company focuses on two systems for treating cancer: growth factor blockers and angiogenesis... more

Stratagene is a developer, manufacturer and marketer of specialized life science research and diagnostic products. The Company's life science research unit supports advances in science by inventing, manufacturing and distributing products that simplify, accelerate and improve research.... more

Lorus Therapeutics Inc. (Lorus) is a life sciences company focused on the discovery, research and development of anticancer therapies. The Company has worked to establish a diverse anticancer product pipeline, with products in various stages of development ranging from pre-clinical to an... more

Celgene Corporation is an integrated biopharmaceutical company. The Company is primarily engaged in the discovery, development and commercialization of therapies designed to treat cancer and immune-inflammatory-related diseases. The Company’s lead product is REVLIMID (lenalidomide) and... more

Geron Corporation (Geron) is developing biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure and diabetes. The Company is advancing telomerase targeted therapies, including an anti-cancer drug and a cancer vaccine,... more

Crucell N.V. (Euronext, NASDAQ: CRXL; Swiss Exchange: CRX) is a global biopharma company focused on research, development, production and marketing of vaccines, proteins and antibodies that prevent and treat primarily infectious diseases. Its vaccines are sold in public and private... more

Millipore Corporation (Millipore) is a life science company that provides products, services and solutions. The Company’s academic, biotechnology, and pharmaceutical customers use its consumable products and services in laboratory applications and in biopharmaceutical manufacturing.... more

Advanced Cell Technology, Inc. is a biotechnology company focused on developing and commercializing human embryonic and adult stem cell technology in the field of regenerative medicine. The Company's business is focused on both the development and commercialization of embryonic stem (ES)... more

Curis, Inc. is a drug discovery and development company committed to leveraging signaling pathway drug technologies in seeking to create new medicines, primarily for cancer. The Company’s product development approach consists of generating small molecules to target one or more of the... more

Cambrex Corporation is a life sciences company engaged primarily in the custom development and manufacture of pharmaceutical ingredients derived from organic chemistry. Products and services are supplied globally to generic drug companies. Cambrex primarily supplies its products and... more

Cephalon, Inc. is an international biopharmaceutical company engaged in the discovery, development and marketing of products to treat human diseases. The Company’s focuses its efforts in four core therapeutic areas: central nervous system (CNS) disorders, pain, cancer and addiction. In... more

Applied Biosystems Inc. (Applied Biosystems) is engaged in the development and marketing of instrument-based systems, consumables, software, and services for academic research, the life science industry and commercial markets. It commercializes technology solutions for deoxyribonucleic... more

ExonHit Therapeutics is a worldleading company in developing novel pharmaceuticals and diagnostics from its unique understanding of alternative RNA splicing, the process by which a single gene can lead to several proteins. The company's proprietary gene profiling technology DATASÔ, allows... more

CytRx Corporation (CytRx) is a clinical-stage biopharmaceutical company engaged in developing human therapeutic products based primarily upon its small-molecule molecular chaperone amplification technology. As of December 31, 2007, the Company is using its chaperone amplification... more

Adherex Technologies Inc. a biopharmaceutical company focused on cancer therapeutics with preclinical and clinical product candidates. The Company has three product candidates in the clinical stage of development. Eniluracil is a dihydropyrimidine dehydrogenase (DPD) inhibitor that was... more

Corixa (Nasdaq: CRXA) is a developer of immunotherapeutics with a commitment to treating and preventing cancer and infectious diseases by understanding and directing the immune system. On June 30, 2003, Corixa announced that the FDA approved BEXXAR for the treatment of patients with CD20... more

ADVENTRX Pharmaceuticals, Inc. is a biopharmaceutical company focused on in-licensing, developing and commercializing product candidates primarily for the treatment of cancer and infectious disease. The Company is focused primarily on advancing ANX-530 and ANX-514, which are emulsion... more

Galapagos is a drug discovery company with two operating divisions: drug discovery and BioFocus DPI, Galapagos' service division. Galapagos' drug discovery division aims to develop novel, disease-modifying drugs in selected bone and joint disease areas for which there is a need for safe... more

Osiris Therapeutics, Inc. (Osiris) is a stem cell therapeutic company, focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic, and cardiovascular areas. The Company’s principal biologic drug candidate, Prochymal, is being evaluated in... more

Sirtris, a GlaxoSmithKline company, is developing small molecule drugs that target the sirtuins, a recently discovered family of seven enzymes associated with the aging process. Modulation of these enzymes offers the promise of drug discovery in multiple therapeutic areas. Founded in... more

GenVec, Inc. (GenVec) is a clinical stage biopharmaceutical company developing gene-based therapeutic drugs and vaccines. Its lead product candidate, TNFerade biologic (TNFerade), is being developed for use in the treatment of cancer. As of December 31, 2007, TNFerade was the subject of a... more

Array BioPharma Inc. (Array) is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs. The Company’s drug development pipeline includes clinical candidates that are designed to treat patients afflicted with cancer,... more

Novozymes is the world leader in bioinnovation. Together with customers across a broad array of industries, we create tomorrow's industrial biosolutions, improving our customers' business and the use of our planet's resources. With over 700 products used in 130 countries, Novozymes'... more

QIAGEN N.V. (QIAGEN) is a provider of technologies and products for preanalytical sample preparation and linked molecular assay solutions. The Company also supplies diagnostic kits, tests, and assays for human and veterinary molecular diagnostics. Products are sold to academic research... more

CancerVax Corporation is a leading edge biotechnology company focused on the discovery, development and commercialization of products for the treatment and control of cancer. CancerVax Corporation is firmly committed to building value by developing innovative products that extend life... more

Dendreon Corporation (Dendreon) is a biotechnology company focused on the discovery, development and commercialization of therapeutics that harness the immune system to fight cancer. Dendreon’s most advanced product candidate is Provenge (sipuleucel-T), an active cellular immunotherapy... more

Biopure Corporation (Biopure) develops, manufactures and markets pharmaceuticals, called oxygen therapeutics, that are intravenously administered to deliver oxygen to the body’s tissues. Hemopure [hemoglobin glutamer-250 (bovine)], or HBOC-201, is approved for sale in South Africa for the... more

Healtheuniverse is developing and intends to commercialize stem cell and regenerative medicine therapies utilizing non-embryonic adult stem cells for use in plastic and reconstructive surgery, orthopedic surgery, vascular surgery, cardiac surgery, and wound care. Headquartered in... more

ViaCell, Inc., a wholly owned subsidiary of PerkinElmer, is dedicated to enabling the widespread application of human cells as medicine. The Company markets ViaCord®, a product offering through which families can preserve their baby's umbilical cord blood at the time of birth for possible... more

Aastrom Biosciences, Inc. (Aastrom) is a regenerative medicine company engaged in the development of autologous cell products for the repair or regeneration of human tissue. The Company’s tissue repair cell (TRC) technology involves the use of a patient’s own cells to manufacture products... more

GPC Biotech AG is a biopharmaceutical company, which is engaged in the discovery, development and commercialization of anticancer drugs. Its lead product candidate is satraplatin, a platinum-based compound intended for use as a chemotherapy treatment. Unlike other platinum-based drugs,... more

Avigen, Inc. is a biopharmaceutical company engaged in developing and commercializing small molecule therapeutics to treat neurological and neuromuscular disorders. The Company’s lead product candidates primarily address spasticity, and neuromuscular spasm and neuropathic pain. Each of... more

VaxGen, Inc. (VaxGen) is a biopharmaceutical company. VaxGen is focused on the development, manufacture and commercialization of biologic products for the treatment of human disease. Its subsidiaries include VaxGen-Celltrion, Inc. (VCI) and Celltrion, Inc. (Celltrion), a company... more

The Immune Response Corporation was co-founded in 1986 by Dr. Jonas Salk, discoverer of the polio vaccine, as a biopharmaceutical company dedicated to treating human immunodeficiency virus (HIV). The Company's lead product candidate, REMUNE®, is an immune-based therapy (IBT) designed by... more

SuperGen, Inc. is a pharmaceutical company dedicated primarily to the discovery, development and commercialization of therapies to treat patients with cancer. The Company acquires products that were developed by other companies and applies additional developmental effort to expand sales... more

OxiGene, Inc. is a clinical-stage, biopharmaceutical company developing therapeutics to treat cancer and eye diseases. The Company’s primary focus is the development and commercialization of product candidates referred to as vascular disrupting agents (VDAs) that selectively disrupt... more

Cyclacel is a biopharmaceutical company that designs and develops small molecule drugs that act on key cell cycle regulators to stop uncontrolled cell division in cancer and other diseases involving abnormal cell proliferation. The Company's discovery engines integrate cell cycle biology... more

Pluristem is a leading biopharmaceutical company developing, producing and marketing stem cell products for cell regenerative therapy. Pluristem's platform for expanding stem cells offers breakthrough technology and multiple product opportunities in many therapeutic areas.

Caliper Life Sciences, Inc. (Caliper) sells products, services and integrated systems comprising of instruments, software and reagents to life sciences, biomedical and pharmaceutical researchers. The Company’s products and services are assembled from its portfolio of microfluidics,... more

EntreMed, Inc. (EntreMed) is a clinical-stage pharmaceutical company focused on developing multi-mechanism oncology drugs that target disease cells and the blood vessels that nourish them. The Company focused on developing drugs that are safe and convenient, and provide the potential for... more

Targeted Genetics Corporation (Targeted Genetics) is a clinical-stage biotechnology company. The Company is engaged in developing and commercializing therapeutic products called gene therapeutics. The product candidate is being developed as a treatment for inflammatory arthritis, and... more

Sunesis Pharmaceuticals, Inc. (Sunesis) is a clinical-stage biopharmaceutical company. The Company focuses on the discovery, development and commercialization of small molecule therapeutics for use in oncology and other diseases. As of December 31, 2007, the Company was advancing three... more

We are a clinical-stage biopharmaceutical company that uses our patented LEX SystemSM to develop hard-to-make therapeutic proteins and monoclonal antibodies that have been optimized to enhance their efficacy and potency. The LEX System is a novel technology that genetically transforms the... more

Cord Blood America, Inc. (CBAI) is primarily a holding company whose subsidiaries include Cord Partners, Inc. (Cord), CorCell Co. Inc., CorCell Ltd., CBA Professional Services, Inc., doing business as BodyCells, Inc. (BodyCells), CBA Properties, Inc. (Properties), and Career Channel Inc,... more

CRT aims to maximise the potential benefit to cancer patients flowing from publicly-funded cancer research worldwide, and in so doing, be recognized as the leading oncology-focused technology transfer and development company. CRT achieves its aim by: Identifying and protecting new... more

TheraVitae is an international biotechnology company at the forefront of regenerative medicine with a mission to make the benefits of adult stem cell therapy accessible and affordable to the millions of people suffering from diseases once seen as incurable.